Work

Tamoxifen pharmacogenetics of CYP2D6, CYP2C19, and SULT1A1: long term follow-up of the North Central Cancer Treatment Group 89-30-52 adjuvant trial.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-6037

Authors: MP Goetz, V Suman, M Ames, J Black, S Safgren, M Kuffel, R Avula, A Moyer, R Weinshilboum, C Reynolds, E Perez, J Ingle

Institutions: Mayo Clinic, Mayo Clinic in Florida

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2067114783

Cites:

Cited by: 6

Related to: 10